S.D. Graham
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Renal cell carcinoma treatment 4
- Prostate Cancer Treatment and Research 1
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Bone health and treatments 1
- Co-authors
- Richard Stephens (1 shared paper)John A. Petros (1 shared paper)Rizk El-Galley (1 shared paper)Thomas E. Keane (1 shared paper)Ihor S. Sawczuk (2 shared papers)R. J. Krane (1 shared paper)Michael E. Osband (1 shared paper)Richard K. Babayan (1 shared paper)
- Journals
- Cancer (1 paper)Urology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)The Prostate (1 paper)The Lancet (1 paper)
- Partner nations
- United States
In The Last Decade
S.D. Graham
9 papers receiving 332 citations
Peers
Comparison fields: 5 of 58
- Oncology 189
- Internal Medicine 18
- Pulmonary and Respiratory Medicine 147
- Immunology 88
- Cancer Research 48
Countries citing papers authored by S.D. Graham
This map shows the geographic impact of S.D. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.D. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.D. Graham more than expected).
Fields of papers citing papers by S.D. Graham
This network shows the impact of papers produced by S.D. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.D. Graham. The network helps show where S.D. Graham may publish in the future.
Co-authors
The 25 scholars most cited alongside S.D. Graham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 112 | |
| 2 | 1990 | 92 | |
| 3 | 1989 | 43 | |
| 4 | 1990 | 40 | |
| 5 | A prospective randomized trial of alpha 2B-interferon/gamma-interferon or the combination in advanced metastatic renal cell carcinoma. | 1988 | 28 |
| 6 | The use of ex vivo-activated memory T cells (autolymphocyte therapy) in the treatment of metastatic renal cell carcinoma: final results from a randomized, controlled, multisite study. | 1993 | 20 |
| 7 | 1985 | 11 | |
| 8 | 1990 | 7 | |
| 9 | 1986 | 2 |
About S.D. Graham
S.D. Graham is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 9 papers that have together received 355 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Renal Diseases and Glomerulopathies (1 paper), Bone health and treatments (1 paper), Prostate Cancer Treatment and Research (1 paper) and Thyroid Disorders and Treatments (1 paper). The work is most often cited by research in Oncology (189 citations), Internal Medicine (18 citations), Pulmonary and Respiratory Medicine (147 citations), Immunology (88 citations) and Cancer Research (48 citations). S.D. Graham has collaborated with scholars based in United States. Frequent co-authors include Richard Stephens, John A. Petros, Rizk El-Galley, Thomas E. Keane, Ihor S. Sawczuk, R. J. Krane, Michael E. Osband, Richard K. Babayan, Barbara A. Parker and Philip T. Lavin. Their work appears in journals such as Cancer, Urology, Journal of Pharmacology and Experimental Therapeutics, The Prostate and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.